(Q83390295)

English

Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors

scientific article published on 01 February 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

Quincy Siu-Chung Chu

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

publication date

1 February 2009

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

published in

Expert Opinion on Biological Therapy

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

volume

9

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

page(s)

263-271

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 January 2020

Identifiers

DOI

10.1517/14712590802666397

1 reference

stated in

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

PubMed ID

19236257

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236257%20AND%20SRC:MED&resulttype=core&format=json

(Q83390295)

Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)